
    
      This is a First in Human, open-label, single arm, dose escalation study in patients with
      advanced leukemias or myelodysplastic syndromes. Patients will receive CYC140 as a 1 hr
      infusion once a week for 2 weeks followed by 1 week of rest on an outpatient basis. One
      treatment cycle is 3 weeks.
    
  